Cargando…

Correction to: CRISPR/Cas: a potential gene-editing tool in the nervous system

Detalles Bibliográficos
Autores principales:	Gao, Yanxia, Gao, Kexin, Yang, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514586/ https://www.ncbi.nlm.nih.gov/pubmed/34643819 http://dx.doi.org/10.1186/s13619-021-00095-3

Ejemplares similares

CRISPR/Cas: a potential gene-editing tool in the nervous system
por: Gao, Yanxia, et al.
Publicado: (2020)

Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy
por: Miri, Seyed Mohammad, et al.
Publicado: (2020)

Correction to: Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

Inflammation conditional genome editing mediated by the CRISPR-Cas9 system
por: Yuan, Tingting, et al.
Publicado: (2023)

Editing the Central Nervous System Through CRISPR/Cas9 Systems
por: Cota-Coronado, Agustin, et al.
Publicado: (2019)

HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
por: Liu, Nan, et al.
Publicado: (2022)

A New Tool for CRISPR-Cas13a-BasedCancer Gene Therapy
por: Gao, Jinliang, et al.
Publicado: (2021)

Correction to: Practical guidance for the implementation of the CRISPR genome editing tool in filamentous fungi
por: Kwon, Min Jin, et al.
Publicado: (2019)

Correction for Lombardi et al., “Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple Candida Species”
por: Lombardi, Lisa, et al.
Publicado: (2020)

TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery
por: Nemudryi, A. A., et al.
Publicado: (2014)

Author Correction: A selectable, plasmid-based system to generate CRISPR/Cas9 gene edited and knock-in mosquito cell lines
por: Rozen-Gagnon, Kathryn, et al.
Publicado: (2021)

Correction: CCTop: An Intuitive, Flexible and Reliable CRISPR/Cas9 Target Prediction Tool
por: Stemmer, Manuel, et al.
Publicado: (2017)

Computational Tools and Resources for CRISPR/Cas Genome Editing
por: Li, Chao, et al.
Publicado: (2023)

Mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs
por: Crippa, Stefania, et al.
Publicado: (2022)

Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
por: Gao, Qianqian, et al.
Publicado: (2019)

Applications of the CRISPR/Cas system beyond gene editing
por: Anton, Tobias, et al.
Publicado: (2018)

Correction to: An optimised CRISPR/Cas9 protocol to create targeted mutations in homoeologous genes and an efficient genotyping protocol to identify edited events in wheat
por: Cui, Xiucheng, et al.
Publicado: (2019)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

Author Correction: Enhanced genome editing efficiency of CRISPR PLUS: Cas9 chimeric fusion proteins
por: Park, Jongjin, et al.
Publicado: (2021)

Off-target effects in CRISPR/Cas9 gene editing
por: Guo, Congting, et al.
Publicado: (2023)

Correction to: “Retraction of: DeepCRISTL: deep transfer learning to predict CRISPR/Cas9 functional and endogenous on-target editing efficiency”
Publicado: (2023)

Publisher Correction to: delivery systems of CRISPR/Cas9-based cancer gene therapy
por: Biagioni, Alessio, et al.
Publicado: (2019)

Author Correction: CRISPR-Cas12a-assisted nucleic acid detection
por: Li, Shi-Yuan, et al.
Publicado: (2019)

Publisher Correction: Correction of a Disease Mutation using CRISPR/Cas9-assisted Genome Editing in Japanese Black Cattle
por: Ikeda, Mitsumi, et al.
Publicado: (2018)

A Single-Chain Photoswitchable CRISPR-Cas9 Architecture for Light-Inducible Gene Editing and Transcription
por: Zhou, Xin X., et al.
Publicado: (2017)

Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System
por: Meneghini, Vasco, et al.
Publicado: (2021)

Harnessing CRISPR-Cas system diversity for gene editing technologies
por: McKay, Alexander, et al.
Publicado: (2021)

Correction to: Rescue of premature aging defects in Cockayne syndrome stem cells by CRISPR/Cas9-mediated gene correction
por: Wang, Si, et al.
Publicado: (2022)

CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
por: Sahel, Deepak Kumar, et al.
Publicado: (2023)

Targeted gene silencing in the nervous system with CRISPR-Cas13
por: Powell, Jackson E., et al.
Publicado: (2022)

Correction: Profiling the impact of the promoters on CRISPR-Cas12a system in human cells
por: Li, Jinhe, et al.
Publicado: (2023)

The CRISPR/Cas Genome-Editing Tool: Application in Improvement of Crops
por: Khatodia, Surender, et al.
Publicado: (2016)

Cell specific single viral vector CRISPR/Cas9 editing and genetically encoded tool delivery in the central and peripheral nervous systems
por: Moffa, Jamie C., et al.
Publicado: (2023)

Genetically Engineering the Nervous System with CRISPR-Cas
por: Sandoval, Alfredo, et al.
Publicado: (2020)

Author Correction: Repurposing type I–F CRISPR–Cas system as a transcriptional activation tool in human cells
por: Chen, Yuxi, et al.
Publicado: (2020)

Correction to: Applications and potential of genome editing in crop improvement
por: Zhang, Yi, et al.
Publicado: (2019)

Efficient gene editing in Corynebacterium glutamicum using the CRISPR/Cas9 system
por: Peng, Feng, et al.
Publicado: (2017)

Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system
por: Cheong, Taek-Chin, et al.
Publicado: (2016)

Gene Editing and Crop Improvement Using CRISPR-Cas9 System
por: Arora, Leena, et al.
Publicado: (2017)

Various Aspects of a Gene Editing System—CRISPR–Cas9
por: Janik, Edyta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sv5c33udikrqejtc1f4k6c7r4t